CRISTOFERI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 3.138
EU - Europa 2.337
AS - Asia 864
SA - Sud America 16
AF - Africa 4
Totale 6.359
Nazione #
US - Stati Uniti d'America 3.117
IT - Italia 794
DE - Germania 376
SG - Singapore 348
SE - Svezia 343
IE - Irlanda 262
RU - Federazione Russa 216
CN - Cina 172
HK - Hong Kong 171
GB - Regno Unito 147
ID - Indonesia 39
IN - India 38
VN - Vietnam 32
FI - Finlandia 31
NL - Olanda 29
FR - Francia 27
DK - Danimarca 20
CA - Canada 19
MY - Malesia 18
UA - Ucraina 17
BE - Belgio 15
AT - Austria 13
TR - Turchia 13
BR - Brasile 9
PT - Portogallo 8
ES - Italia 7
IL - Israele 7
CZ - Repubblica Ceca 6
NO - Norvegia 6
SK - Slovacchia (Repubblica Slovacca) 6
TW - Taiwan 6
GR - Grecia 4
IQ - Iraq 4
LT - Lituania 4
MM - Myanmar 4
AR - Argentina 3
EC - Ecuador 3
KR - Corea 3
CH - Svizzera 2
GH - Ghana 2
IR - Iran 2
JP - Giappone 2
PK - Pakistan 2
RO - Romania 2
BG - Bulgaria 1
CO - Colombia 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
LK - Sri Lanka 1
PA - Panama 1
PH - Filippine 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 6.359
Città #
Ann Arbor 862
Frankfurt am Main 337
Singapore 307
Milan 281
Dublin 248
Fairfield 231
Chandler 220
Wilmington 178
Hong Kong 164
New York 124
Ashburn 120
Chicago 105
Woodbridge 104
Santa Clara 102
London 90
Seattle 89
Houston 84
Cambridge 81
Princeton 72
Shanghai 64
Rome 48
Dearborn 44
Jakarta 39
Lawrence 35
Altamura 28
Florence 25
Helsinki 25
Beijing 24
Boardman 21
San Diego 21
Monza 17
Pune 17
Penang 16
Los Angeles 15
Nanjing 15
Brussels 14
Jacksonville 13
Turin 13
Andover 12
Bologna 11
Modena 9
Paris 9
Seregno 9
Toronto 9
Bari 8
Lisbon 8
Mumbai 8
Fremont 7
Guangzhou 7
Naples 7
Treviglio 7
Vienna 7
Bratislava 6
Brno 6
Central 6
Desio 6
Detroit 6
Genoa 6
Kocaeli 6
Lissone 6
Padova 6
Cagliari 5
Delmar 5
Hangzhou 5
Lappeenranta 5
São Paulo 5
Appiano Gentile 4
Castiglione del Lago 4
Changsha 4
Council Bluffs 4
Dong Ket 4
Jiaxing 4
Jinan 4
Kilburn 4
Meda 4
Munich 4
Norwalk 4
Nuremberg 4
Shenyang 4
Udine 4
Amsterdam 3
Athens 3
Carate Brianza 3
Chioggia 3
Comazzo 3
Cossato 3
Dongguan 3
Edmonton 3
Falls Church 3
Garbagnate Milanese 3
Giv‘at Shmuel 3
Hebei 3
Hounslow 3
Huizen 3
Istanbul 3
Kunming 3
Lodi 3
Lucca 3
Moscow 3
New Taipei 3
Totale 4.606
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 427
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 237
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 236
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 194
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 188
Precision medicine in primary biliary cholangitis 186
Risk stratification in primary sclerosing cholangitis 180
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 177
Endocrinology and Metabolic Diseases (Including Diabetes) 171
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 168
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 167
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 166
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 165
New Therapeutic Targets in Autoimmune Cholangiopathies 159
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 154
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 153
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 153
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 145
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 141
Prognostic models in primary biliary cholangitis 137
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 132
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 130
Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis" 127
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat 126
RADIOLOGY-BASED BIOMARKERS DISCOVERY IN PRIMARY SCLEROSING CHOLANGITIS: FROM RISK STRATIFICATION TO THE EVALUATION OF TREATMENT BENEFIT 123
The immunobiology of female predominance in primary biliary cholangitis 120
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 112
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 109
Fibrocystic liver disease 109
Geoepidemiology and (epi-)genetics in primary biliary cholangitis 101
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 91
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 84
A Smooth Esophageal Stricture Causing Dysphagia 81
Individualizing Care: Management Beyond Medical Therapy 79
Prevalence of upper gastrointestinal endoscopic findings in the community: A systematic review of studies in unselected samples of subjects 76
Antioxidant treatment for acute pancreatitis 72
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 71
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 70
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis 67
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 67
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 66
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 63
Artificial intelligence for precision medicine in autoimmune liver disease 62
Transient elastography in chronic liver disease: beware to the cut-offs! 58
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? 58
An update on novel pharmacological agents for primary sclerosing cholangitis 54
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 53
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 52
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 51
X marks the spot in autoimmunity 48
The Role of Epigenetics in Primary Biliary Cholangitis 43
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 43
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis 39
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 38
Systematic review-Pancreatic involvement in inflammatory bowel disease 37
Primary Sclerosing Cholangitis 37
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement 36
Elastography in Autoimmune Liver Diseases 34
European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care 30
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 26
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 24
Individualizing Care: Management Beyond Medical Therapy 23
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 21
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 21
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 17
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 15
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 13
Totale 6.713
Categoria #
all - tutte 30.021
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.021


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020325 0 0 0 0 0 0 80 59 59 69 42 16
2020/20211.133 29 25 184 66 88 121 101 130 89 78 115 107
2021/2022772 100 98 140 80 43 41 14 42 39 32 53 90
2022/20231.439 118 329 125 93 152 181 108 69 101 47 76 40
2023/20241.363 45 65 67 134 145 271 181 28 69 98 45 215
2024/20251.251 195 303 153 143 233 130 94 0 0 0 0 0
Totale 6.713